$23.03
0.090.39%
In chiusura: Nov 21, 4:00 PM EST
$22.81
-0.22-0.93%
After hour: Nov 21, 6:16 PM EST
Avadel Pharmaceuticals fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/07/2025 | AVDL | Avadel Pharmaceuticals | Q3 | 2025 | — | — | — | $71.00M | $75.00M | $70.56M | |
08/07/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $265.00M | $275.00M | $260.18M | |
05/07/2025 | AVDL | Avadel Pharmaceuticals | Q2 | 2025 | — | — | — | $60.00M | $63.00M | $58.21M | |
05/07/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $255.00M | $265.00M | $249.16M | |
03/03/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $240.00M | $260.00M | $250.35M | |
01/08/2025 | AVDL | Avadel Pharmaceuticals | FY | 2024 | — | — | — | $169.00M | $169.00M | $171.41M | |
01/08/2025 | AVDL | Avadel Pharmaceuticals | Q4 | 2024 | — | — | — | $50.00M | $50.00M | $52.70M | |
01/08/2025 | AVDL | Avadel Pharmaceuticals | FY | 2025 | — | — | — | $240.00M | $260.00M | $291.34M |
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Avadel Pharmaceuticals.
Sfoglia guidance e previsioni su tutte le azioni.